{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:56:39Z","timestamp":1793055399498,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004429","name":"University of Crete","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cmi.2025.02.018","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:06:14Z","timestamp":1739847974000},"page":"1033-1039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Mortality due to carbapenem-resistant Acinetobacter baumannii bacteraemia: a 5-year cohort study in intensive care patients"],"prefix":"10.1016","volume":"31","author":[{"given":"Stamatis","family":"Karakonstantis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos I.","family":"Kritsotakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renatos-Nikolaos","family":"Tziolos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loukia","family":"Vassilopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Loukaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Kypraiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil C.","family":"Petrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Tovil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Kokkini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki","family":"Tryfinopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0395umorfia","family":"Kondili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diamantis P.","family":"Kofteridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.02.018_bib1","first-page":"271","article-title":"Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options","volume":"75","author":"Karakonstantis","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.02.018_bib2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s15010-020-01520-6","article-title":"Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems","volume":"48","author":"Karakonstantis","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2025.02.018_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3390\/antibiotics13050423","article-title":"Treatment strategies of colistin resistance Acinetobacter baumannii infections","volume":"13","author":"Papazachariou","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2025.02.018_bib4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/antibiotics11060723","article-title":"Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance","volume":"11","author":"Karakonstantis","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2025.02.018_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cmi.2023.08.029","article-title":"Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"30","author":"Karakonstantis","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.02.018_bib6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10096-023-04616-7","article-title":"In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020\u20132021: a multicenter study","volume":"42","author":"Galani","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2025.02.018_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/pathogens12020286","article-title":"Efficacy of fosfomycin-containing regimens for treatment of bacteremia due to pan-drug resistant Acinetobacter baumannii in critically ill patients: a case series study","volume":"12","author":"Assimakopoulos","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.cmi.2025.02.018_bib8","first-page":"11","article-title":"Triple combination therapy with high-dose ampicillin\/sulbactam, high-dose tigecycline and colistin in the treatment of ventilator-associated pneumonia caused by pan-drug resistant Acinetobacter baumannii: a case series study","volume":"27","author":"Assimakopoulos","year":"2019","journal-title":"Infez Med"},{"key":"10.1016\/j.cmi.2025.02.018_bib9","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3390\/antibiotics10111344","article-title":"Systematic review of antimicrobial combination options for pandrug-resistant Acinetobacter baumannii","volume":"10","author":"Karakonstantis","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.cmi.2025.02.018_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s15010-021-01748-w","article-title":"In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations","volume":"50","author":"Karakonstantis","year":"2022","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2025.02.018_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/cc5911","article-title":"Attributable mortality of Acinetobacter baumannii: No longer a controversial issue","volume":"11","author":"Falagas","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2025.02.018_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/epirev\/mxab001","article-title":"Burden of antimicrobial resistance: compared to what?","volume":"43","author":"de Kraker","year":"2022","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.cmi.2025.02.018_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jhin.2020.09.009","article-title":"Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients","volume":"106","author":"Karakonstantis","year":"2020","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2025.02.018_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jhin.2024.07.016","article-title":"Limited impact of colistin resistance on mortality of intensive care patients with carbapenem-resistant bacteraemia","volume":"153","author":"Tziolos","year":"2024","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2025.02.018_bib15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cid\/ciy988","article-title":"Treatment outcomes of colistin and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial","volume":"69","author":"Dickstein","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.02.018_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00725-24","article-title":"Polymyxins retain in vitro activity and in vivo efficacy against \u201cresistant\u201d Acinetobacter baumannii strains when tested in physiological conditions","volume":"68","author":"Rubio","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.02.018_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1120009X.2020.1794393","article-title":"A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline in Acinetobacter baumannii","volume":"33","author":"Karakonstantis","year":"2020","journal-title":"J Chemother (Florence, Italy)"},{"key":"10.1016\/j.cmi.2025.02.018_bib18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s15010-021-01663-0","article-title":"Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (versus monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex","volume":"49","author":"Karakonstantis","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2025.02.018_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/EDE.0000000000001307","article-title":"Addressing competing risks when assessing the impact of health services interventions on hospital length of stay","volume":"32","author":"Batomen","year":"2021","journal-title":"Epidemiology"},{"key":"10.1016\/j.cmi.2025.02.018_bib20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jclinepi.2012.09.017","article-title":"A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions","volume":"66","author":"Latouche","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cmi.2025.02.018_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jclinepi.2020.03.004","article-title":"Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis","volume":"122","author":"Schuster","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cmi.2025.02.018_bib22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cmi.2025.02.018_bib23","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1017\/S0950268822001492","article-title":"Burden of multidrug and extensively drug-resistant ESKAPEE pathogens in a secondary hospital care setting in Greece","volume":"150","author":"Kritsotakis","year":"2022","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2025.02.018_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12879-016-1695-8","article-title":"Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis","volume":"16","author":"Le\u00e3o","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2025.02.018_bib25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jhin.2006.06.025","article-title":"The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes","volume":"64","author":"Robenshtok","year":"2006","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2025.02.018_bib26","doi-asserted-by":"crossref","first-page":"e02562","DOI":"10.1128\/AAC.02562-17","article-title":"Comparison of septic shock due to multidrug-resistant Acinetobacter baumannii or Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit patients","volume":"62","author":"Russo","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.02.018_bib27","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.1038\/s41598-022-12482-0","article-title":"Different clinical characteristics and impact of carbapenem-resistance on outcomes between Acinetobacter baumannii and Pseudomonas aeruginosa bacteraemia: a prospective observational study","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2025.02.018_bib28","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S1473-3099(23)00184-6","volume":"23","author":"Kaye","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2025.02.018_bib29","doi-asserted-by":"crossref","first-page":"107167","DOI":"10.1016\/j.ijantimicag.2024.107167","article-title":"Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: New data from CREDIBLE-CR with an updated meta-analysis","volume":"63","author":"Gill","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2025.02.018_bib30","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/cid\/ciad100","article-title":"Mortality attributable to bloodstream infections caused by different carbapenem-resistant Gram-negative bacilli: results from a nationwide study in Italy (ALARICO Network)","volume":"76","author":"Falcone","year":"2023","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:10:23Z","timestamp":1780279823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1198743X25000795"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.02.018","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality due to carbapenem-resistant Acinetobacter baumannii bacteraemia: a 5-year cohort study in intensive care patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.04.043","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}